1 Cyanidin-3--Glucoside and Cyanidin Protect Against Intestinal Barrier Damage and 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis.

2 Modulation of gut microbiota by Ilex kudingcha improves dextran sulfate sodium-induced colitis.

3 Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.

4 Yersiniabactin-Producing Adherent/Invasive Escherichia coli Promotes Inflammation-Associated Fibrosis in Gnotobiotic Mice.

5 Characteristics and outcomes of acute colitis diagnosed on cross-sectional imaging presenting via the emergency department in an Irish academic medical centre.

6 Filtered Kombucha tea ameliorates the leaky gut syndrome in young and old mice model of colitis.

7 reactive oxygen species deficiency due to ncf1-mutation leads to development of adenocarcinoma and metabolomic and lipidomic remodeling in a new mouse model of dextran sulfate sodium-induced colitis

8 december 2016 critical care case of the month

9 qualidade de vida de pacientes portadores de doença inflamatória intestinal calidad de vida de pacientes portadores de enfermedad inflamatoria intestinal quality of life of patients with inflammatory bowel disease

10 traditional herbal medicine-derived sulforaphene lfs-01 reverses colitis in mice by selectively altering the gut microbiota and promoting intestinal gamma-delta t cells

11 acute mesenteric ischemia: a sequela of abdominal aortography

12 combined treatment with hyaluronic acid and mesalamine protects rats from inflammatory bowel disease induced by intracolonic administration of trinitrobenzenesulfonic acid

13 severe colitis associated with both epstein-barr virus and cytomegalovirus reactivation in a patient with severe aplastic anemia

14 the effect of oral intake of low-temperature-processed whey protein concentrate on colitis and gene expression profiles in mice

15 endoscopic diagnosis and differentiation of inflammatory bowel disease

16 fecal microbiota transplantation: current applications, effectiveness, and future perspectives

17 ulcerative colitis and systemic sclerosis

18 The role of cholinergic anti-inflammatory pathway in acetic acid-induced colonic inflammation in the rat.

19 The effect of phosphodiesterase-5 inhibition by sildenafil citrate on inflammation and apoptosis in rat experimental colitis.

20 Phosphodiesterase-5 inhibition by sildenafil citrate in a rat model of bleomycin-induced lung fibrosis.

21 Halofuginone has a beneficial effect on gentamicin-induced acute nephrotoxicity in rats.

22 The effect of sildenafil, a phosphodiesterase-5 inhibitor, on acetic acid-induced colonic inflammation in the rat.

23 Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis.

24 Protective role of adrenomedullin in burn-induced remote organ damage in the rat.

25 Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats.

26 Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.

27 [Clinical observations on ulcerative colitis, with special reference to 3 cases showing severe nervous symptoms during the course of the disease].

28 Anti-Colitic Effects of Ethanol Extract of Mill. through Suppression of Pro-Inflammatory Mediators via NF-κB/STAT3 Inactivation in Dextran Sulfate Sodium-Induced Colitis Mice.

29 Effect of Shogaol on the Expression of Intestinal Stem Cell Markers in Experimentally Induced Colitis in BALB/c Mice

30 Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis

31 The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis

32 The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis

33 Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression

34 Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis

35 Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.

36 Consenso mexicano para el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática

37 Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

38 A Metagenomics Study on Hirschsprung's Disease Associated Enterocolitis: Biodiversity and Gut Microbial Homeostasis Depend on Resection Length and Patient's Clinical History.

39 The combination of indirubin and isatin attenuates dextran sodium sulfate induced ulcerative colitis in mice.

40 Protective effect of Lactobacillus fermentum CQPC04 on dextran sulfate sodium-induced colitis in mice is associated with modulation of the nuclear factor-κB signaling pathway.

41 Endoscopy in Postoperative Patients with Crohn's Disease or Ulcerative Colitis. Does It Translate to Better Outcomes?

42 [Method of diagnosis of the severity of the disease attack in patients with ulcerative colitis.]

43 Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.

44 Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis

45 Appropriate Timing of Discontinuation of Tacrolimus Therapy for Refractory Ulcerative Colitis

46 Hyaluronan 35 kDa enhances epithelial barrier function and protects against the development of murine necrotizing enterocolitis.

47 Ambient air quality as risk factor for microscopic colitis - A geographic information system (GIS) study.

48 Application of a DSS colitis model in toxicologically assessing norisoboldine.

49 Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam.

50 Analgesic effect of resveratrol on colitis-induced visceral pain via inhibition of TRAF6/NF-κB signaling pathway in the spinal cord.

51 Necrotizing enterocolitis - classification and two initial steps towards prevention.

52 Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.

53 Nutritional interventions to reduce rates of infection, necrotizing enterocolitis and mortality in very preterm infants.

54 Microscopic colitis: diagnosis and management.

55 Healing effects of Cornus mas L. in experimentally induced ulcerative colitis in rats: From ethnobotany to pharmacology.

56 Healing effects of Cornus mas L. in experimentally induced ulcerative colitis in rats: From ethnobotany to pharmacology

57 Aqueous Extract of Brazilian Berry () Peel Improves Inflammatory Parameters and Modulates and in Rats with Induced-Colitis.

58 Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis.

59 Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?

60 Saccharomyces cerevisiaeCNCMI-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease

61 AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition

62 Tu2024 AIEC Instigates Chronic Colitis by Altering Microbiota Composition and Its Inherent Pro-Inflammatory Potential

63 Sa1753 Vertical Transmission of AIEC Pathobiont Increases Severity of DSS-Induced Colitis in Offspring

64 Functional and quality of life outcomes after ileal pouch-anal anastomosis in short versus long ileal J-pouch configuration in ulcerative colitis patients: a cohort study.

65 Dysregulation of miR-431 and target gene FOXA1 in intestinal tissues of infants with necrotizing enterocolitis.

66 Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats.

67 Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis

68 Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice.

69 Maternal High Fat Diet Alters Gut Microbiota of Offspring and Exacerbates DSS-Induced Colitis in Adulthood

70 Ulcerative Colitis: A Critical Approach to the Global Research Output Employing Density-equalizing Mapping and Scientometric Methods.

71 Effects of Aqueous and Methanolic Extracts of Stem Bark of De Wild. (Apocynaceae) on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Wistar Rats.

72 Rapid expansion of Treg cells protects from collateral colitis following a viral trigger

73 Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study.

74 Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

75 Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1

76 Chemotaxonomic Analysis of Bacterial Populations Colonizing the Rectal Mucosa in Patients with Ulcerative Colitis

77 Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis

78 Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis

79 Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis

80 Vedolizumab for induction and maintenance of remission in ulcerative colitis

81 Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis

82 Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

83 Effectiveness and Nephrotoxicity of Long-Term Tacrolimus Administration in Patients with Ulcerative Colitis

84 Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

85 Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

86 Vedolizumab as induction and maintenance therapy for ulcerative colitis

87 Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

88 Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life

89 Psychological status in Iranian patients with ulcerative colitis and its relation to disease activity and quality of life

90 Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients

91 nrf-2 expression in ulcerative colitis lesions and its correlation with antioxidant enzyme levels and tissue injury

92 factores de riesgo asociados a la mortalidad por enterocolitis necrotizante

93 pseudomembranous colitis: not always caused by clostridium difficile

94 the crohn’s and colitis foundation of canada: a time for reflection and strategic planning for the future

95 intestinal anti-inflammatory effects of outer membrane vesicles from escherichia coli nissle 1917 in dss-experimental colitis in mice

96 possibility of interstitial lung disease as a phlebosclerotic colitis manifestation

97 sucralose promotes colitis-associated colorectal cancer risk in a murine model along with changes in microbiota

98 boehmeria nivea attenuates the development of dextran sulfate sodium-induced experimental colitis

99 markers of hypoxia correlate with histologic and endoscopic severity of colitis in inflammatory bowel disease

100 paraoxonase and arylesterase activities, lipid profile, and oxidative damage in experimental ischemic colitis model

101 participation of some campylobacter species in the etiology of enterocolitis

Keyword Connections

Journals

Research Groups

Bibliographies